Biopolymer Hydroxypropyl Methylcellulose-Based Filaments Prepared by Hot-Melt Extrusion Suitable for Fused Deposition Modeling 3D Printing of Personalized Capsules
Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
41341004
PubMed Central
PMC12670669
DOI
10.1089/3dp.2024.0030
PII: 10.1089/3dp.2024.0030
Knihovny.cz E-zdroje
- Klíčová slova
- 3D printing, biopolymers, capsules, fused deposition modeling, hot-melt extrusion,
- Publikační typ
- časopisecké články MeSH
Materials based on the hydroxypropyl methylcellulose mixed with different biopolymers (BioP; 5 w% of chitosan, sodium alginate, apple pectin, or citrus pectin) were processed by hot-melt extrusion and 3D printing to produce capsules intended for controlled drug release. Microscopic analyses confirmed significant impact of BioP on the processing temperatures and quality of the 3D printing. The capsules' chemical composition had a more significant impact on the dissolution profiles in acidic and neutral media, which are a robust function of the intermolecular bonds and swelling characteristics of the particular BioP (as indicated by the combined results of Raman spectroscopy, differential scanning calorimetry [DSC], and thermogravimetry). The capsules of all tested compositions retained the model drug for 120 min in pH 1.2, i.e., fulfilled the condition of targeting the small intestine. The presence of the particular BioP was found to be particularly beneficial in the development of personalized capsules for oral administration. The addition of both pectins led to a relatively fast pH-independent release of the model drug and has the potential applications in the targeting of the duodenum or jejunum. The capsules containing alginate and chitosan exhibited later initial release in pH 1.2, guaranteeing an unaltered passage through the stomach environment.
Zobrazit více v PubMed
Viidik L, Vesala J, Laitinen R, et al. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets. Eur J Pharm Sci 2021;158:105619; doi: 10.1016/j.ejps.2020.105619 PubMed DOI
Karalia D, Siamidi A, Karalis V, et al. 3D-printed oral dosage forms: Mechanical properties, computational approaches and applications. Pharmaceutics 2021;13(9); doi: 10.3390/pharmaceutics13091401 PubMed DOI PMC
LaFountaine JS, McGinity JW, Williams RO. Challenges and strategies in thermal processing of amorphous solid dispersions: A review. AAPS. PharmSciTech 2016;17(1):43–55; doi: 10.1208/s12249-015-0393-y PubMed DOI PMC
Patil H, Tiwari RV, Repka MA. Hot-melt extrusion: From theory to application in pharmaceutical formulation. AAPS PharmSciTech 2016;17(1):20–42; doi: 10.1208/s12249-015-0360-7 PubMed DOI PMC
Gupta SS, Solanki N, Serajuddin ATM. Investigation of thermal and viscoelastic properties of polymers relevant to hot melt extrusion, IV: AffinisolTM HPMC HME polymers. AAPS PharmSciTech 2016;17(1):148–157; doi: 10.1208/s12249-015-0426-6 PubMed DOI PMC
Aho J, Bøtker JP, Genina N, et al. Roadmap to 3D-printed oral pharmaceutical dosage forms: Feedstock filament properties and characterization for fused deposition modeling. J Pharm Sci 2019;108(1):26–35; doi: 10.1016/j.xphs.2018.11.012 PubMed DOI
Douroumis D. Hot-melt extrusion: Pharmaceutical applications. 1st ed. John Wiley & Sons; 2012.
Lauer ME, Maurer R, Paepe ATD, et al. A miniaturized extruder to prototype amorphous solid dispersions: Selection of plasticizers for hot melt extrusion. Pharmaceutics 2018;10(2):58; doi: 10.3390/pharmaceutics10020058 PubMed DOI PMC
Wesholowski J, Hoppe K, Nickel K, et al. Scale-up of pharmaceutical hot-melt-extrusion: Process optimization and transfer. Eur J Pharm Biopharm 2019;142:396–404; doi: 10.1016/j.ejpb.2019.07.009 PubMed DOI
Pereira GG, Figueiredo S, Fernandes AI, et al. Polymer selection for hot-melt extrusion coupled to fused deposition modelling in pharmaceutics. Pharmaceutics 2020;12(9):795; doi: 10.3390/pharmaceutics12090795 PubMed DOI PMC
Fukuda M, Peppas NA, McGinity JW. Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum. Int J Pharm 2006;310(1–2):90–100; doi: 10.1016/j.ijpharm.2005.11.042 PubMed DOI
Censi R, Gigliobianco MR, Casadidio C, et al. Hot melt extrusion: Highlighting physicochemical factors to be investigated while designing and optimizing a hot melt extrusion process. Pharmaceutics 2018;10(3):89; doi: 10.3390/pharmaceutics10030089 PubMed DOI PMC
Nashed N, Lam M, Nokhodchi A. A comprehensive overview of extended release oral dosage forms manufactured through hot melt extrusion and its combination with 3D printing. Int J Pharm 2021;596:120237; doi: 10.1016/j.ijpharm.2021.120237 PubMed DOI
Manini G, Benali S, Raquez JM, et al. Proof of concept of a predictive model of drug release from long-acting implants obtained by fused-deposition modeling. Int J Pharm 2022;618:121663; doi: 10.1016/j.ijpharm.2022.121663 PubMed DOI
Zhang J, Thakkar R, Zhang Y, et al. Structure-function correlation and personalized 3D printed tablets using a Quality By Design (QbD) approach. Int J Pharm 2020;590:119945; doi: 10.1016/j.ijpharm.2020.119945 PubMed DOI
Ilyés K, Kovács NK, Balogh A, et al. The applicability of pharmaceutical polymeric blends for the Fused Deposition Modelling (FDM) 3D technique: Material considerations-printability-process modulation, with consecutive effects on in vitro release, stability and degradation. Eur J Pharm Sci 2019;129:110–123; doi: 10.1016/j.ejps.2018.12.019 PubMed DOI
Boetker J, Water JJ, Aho J, et al. Modifying release characteristics from 3D printed drug-eluting products. Eur J Pharm Sci 2016;90:47–52; doi: 10.1016/j.ejps.2016.03.013 PubMed DOI
Tsintavi E, Rekkas DM, Bettini R. Partial tablet coating by 3D printing. Int J Pharm 2020;581:119298; doi: 10.1016/j.ijpharm.2020.119298 PubMed DOI
Melocchi A, Parietti F, Maroni A, et al. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling. Int J Pharm 2016;509(1–2):255–263; doi: 10.1016/j.ijpharm.2016.05.036 PubMed DOI
Skalická B, Matzick K, Komersová A, et al. 3D-printed coating of extended-release matrix tablets: Effective tool for prevention of alcohol-induced dose dumping effect. Pharmaceutics 2021;13(12); doi: 10.3390/pharmaceutics13122123 PubMed DOI PMC
Teruel AH, Gonzalez-Alvarez I, Bermejo M, et al. New insights of oral colonic drug delivery systems for inflammatory bowel disease therapy. Int J Mol Sci 2020;21(18); doi: 10.3390/ijms21186502 PubMed DOI PMC
Franc A, Vetchý D, Fülöpová N. Commercially available enteric empty hard capsules: Production technology and application. Pharmaceuticals 2022;15(11):1398; doi: 10.3390/ph15111398 PubMed DOI PMC
Matijašić G, Gretić M, Vinčić J, et al. Design and 3D printing of multi-compartmental PVA capsules for drug delivery. J Drug Deliv Sci Technol 2019;52:677–686; doi: 10.1016/j.jddst.2019.05.037 DOI
Okwuosa TC, Sadia M, Isreb A, et al. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment. Int J Pharm 2021;600:120442; doi: 10.1016/j.ijpharm.2021.120442 PubMed DOI
Zhao X, Wei W, Niu R, et al. 3D printed intragastric floating and sustained-release tablets with air chambers. J Pharm Sci 2022;111(1):116–123; doi: 10.1016/j.xphs.2021.07.010 PubMed DOI
Đuranović M, Madžarević M, Ivković B, et al. The evaluation of the effect of different superdisintegrants on the drug release from FDM 3D printed tablets through different applied strategies: In vitro-in silico assessment. Int J Pharm 2021;610:121194; doi: 10.1016/j.ijpharm.2021.121194 PubMed DOI
Rede K, Felicijan T, Bogataj M. Exploring the unexpected behavior of HPMC matrix tablets in dissolution media with SDS. J Drug Deliv Sci Technol 2021;66:102801; doi: 10.1016/j.jddst.2021.102801 DOI
Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2001;48(2–3):139–157; doi: 10.1016/S0169-409X(01)00112-0 PubMed DOI
Tung NT, Pham TMH, Nguyen TH, et al. Pectin/HPMC dry powder coating formulations for colon specific targeting tablets of metronidazole. J Drug Deliv Sci Technol 2016;33:19–27; doi: 10.1016/j.jddst.2016.03.004 DOI
Augsburger LL, Hoag SW. Pharmaceutical Dosage Forms: Capsules. 1st ed. London: Taylor & Francis; 2017.
Yang N, Chen H, Jin Z, et al. Moisture sorption and desorption properties of gelatin, HPMC and pullulan hard capsules. Int J Biol Macromol 2020;159:659–666; doi: 10.1016/j.ijbiomac.2020.05.110 PubMed DOI
Prasad E, Islam MT, Goodwin DJ, et al. Development of a hot-melt extrusion (HME) process to produce drug loaded AffinisolTM 15LV filaments for fused filament fabrication (FFF) 3D printing. Addit Manuf 2019; doi: 10.1016/j.addma.2019.06.027 DOI
Huang S, O’Donnell KP, Keen JM, et al. A new extrudable form of hypromellose: AFFINISOLTM HPMC HME. AAPS PharmSciTech 2016;17(1):106–119; doi: 10.1208/s12249-015-0395-9 PubMed DOI PMC
Fülöpová N, Pavloková S, DeBono I, et al. Development and comparison of various coated hard capsules suitable for enteric administration to small patient cohorts. Pharmaceutics 2022;14(8); doi: 10.3390/pharmaceutics14081577 PubMed DOI PMC
Timmins P, Pygall SR, Melia CD. Hydrophilic Matrix Tablets for Oral Controlled Release. New York: Springer; 2014.
Newton AMJ, Lakshmanan P. Effect of HPMC—E15 LV premium polymer on release profile and compression characteristics of chitosan/pectin colon targeted mesalamine matrix tablets and in vitro study on effect of ph impact on the drug release profile. Recent Pat Drug Deliv Formul 2014;8(1):46–62; doi: 10.2174/1872211308666140225143926 PubMed DOI
Wu B, Deng D, Lu Y, et al. Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: II. Influencing variables, stability and pharmacokinetics in dogs. Eur J Pharm Biopharm 2008;69(1):294–302; doi: 10.1016/j.ejpb.2007.10.001 PubMed DOI
Mujtaba A, Kohli K. In vitro/in vivo evaluation of HPMC/alginate based extended-release matrix tablets of cefpodoxime proxetil. Int J Biol Macromol 2016;89:434–441; doi: 10.1016/j.ijbiomac.2016.05.010 PubMed DOI
Huang YB, Tsai YH, Lee SH, et al. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int J Pharm 2005;289(1–2):87–95; doi: 10.1016/j.ijpharm.2004.10.021 PubMed DOI
Hachimi T, Naboulsi N, Majid F, et al. Design and manufacturing of a 3D printer filaments extruder. Procedia Struct. Integr 2021;33:907–916; doi: 10.1016/j.prostr.2021.10.101 DOI
Krishnanand K, Soni S, Taufik M. Design and assembly of Fused Filament Fabrication (FFF) 3D printers. Mater 2021;46:5233–5241; doi: 10.1016/j.matpr.2020.08.627 DOI
Agarwal UP. Analysis of cellulose and lignocellulose materials by raman spectroscopy: A review of the current status. Molecules 2019;24(9); doi: 10.3390/molecules24091659 PubMed DOI PMC
Council of Europe—EDQM . European Pharmacopoeia. 11th ed.; Council of Europe Strasbourg: France; 2021.